Chapter 32. Ethical Issues in Hematopoietic Cell Transplantation

  1. Frederick R. Appelbaum MD Member Director Professor Head2,3,
  2. Stephen J. Forman MD Director Staff Physician4,5,
  3. Robert S. Negrin MD Professor of Medicine Chief6 and
  4. Karl G. Blume MD, FACP Emeritus Professor of Medicine6,7
  1. David S. Snyder MD Chair City of Hope Bioethics Committee Associate Director

Published Online: 5 MAR 2009

DOI: 10.1002/9781444303537.ch32

Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

How to Cite

Snyder, D. S. (2009) Ethical Issues in Hematopoietic Cell Transplantation, in Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition (eds F. R. Appelbaum, S. J. Forman, R. S. Negrin and K. G. Blume), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303537.ch32

Editor Information

  1. 2

    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

  2. 3

    Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington, USA

  3. 4

    Department of Hematology and Hematopoietic Cell Transplantation, Duarte, California, USA

  4. 5

    Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA

  5. 6

    Division of Blood and Marrow Transplantation, Stanford University, Stanford, California, USA

  6. 7

    Division of Bone Marrow Transplantation, Department of Medicine, Stanford University, School of Medicine, Stanford, California, USA

Author Information

  1. Division of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, Calitornia, USA

Publication History

  1. Published Online: 5 MAR 2009
  2. Published Print: 27 FEB 2009

ISBN Information

Print ISBN: 9781405153485

Online ISBN: 9781444303537

SEARCH

Keywords:

  • ethical issues in hematopoietic cell transplantation;
  • Informed consent for patients undergoing HCT;
  • Informed consent for donors of hematopoietic cells;
  • Alternative sources of hematopoietic cells;
  • transplantation for nonmalignant diseases;
  • end-of-life issues

Summary

This chapter contains sections titled:

  • Introduction

  • Who is eligible for HCT?

  • Informed consent for patients undergoing HCT

  • Informed consent for donors of hematopoietic cells

  • Alternative sources of hematopoietic cells

  • Transplantation for nonmalignant diseases

  • End-of-life issues

  • Closing remarks

  • References